Research entities established in Lithuania participating in Community research programmes, shall, as regards ownership, exploitation and dissemination of information and intellectual property arising from such participation, have the same rights and obligations as those of research entities established in the Community, subject to the provisions of Annex II.
Σημαντικές ανεπιθύμητες ενέργειες Μυελοκαταστολή: η θεραπεία με το dasatinib σχετίζεται με αναιμία, ουδετεροπενία και θρομβοπενίαEurLex-2 EurLex-2